The skeleton is a unique structure capable of providing support for the body. Bone
resorption and deposition are controlled in a tightly regulated balance between osteoblasts …

Patients with non-small cell lung cancer (NSCLC) develop bone metastasis (BoM) in more
than 50% of cases during the course of the disease. This metastatic site can lead to the …

Objective In the 10 most common primary types with bone metastases, we aimed to examine
survival, further stratifying on bone metastases only or with additional synchronous …

Immunotherapy with checkpoint inhibitor programmed cell death 1 (PD-1)/programmed
death ligand-1 (PD-L1) antibodies demonstrates improvements in treatment of advanced …

Bone represents a common site of metastasis from several solid tumours, including breast,
prostate and lung malignancies. The onset of bone metastases (BM) is associated not only …

Purpose Heterogeneity is found in the tumor microenvironment among different pathological
types of tumors. Radionuclide-labeled fibroblast-activation-protein inhibitor (FAPI), as an …

Exercise training is playing an increasing role in lung cancer care. Lung cancer is
associated with significant burden to the individual and healthcare system. There is now …

Introduction Bone metastases (BMs) are a negative prognostic factor in patients with non-
small cell lung cancer (NSCLC). Although immune-checkpoint inhibitors (ICIs) have …

The risk factors of bone metastasis in patients with lung cancer are still unclear. Here, a
retrospective study including a series of consecutive patients who were diagnosed with lung …

Lung cancer is the leading cause of cancer-related death worldwide. Bone metastasis,
which usually accompanies severe skeletal-related events, is the most common site for …